| P/E (FY) | — | Sales (TTM) | $22.5M |
| Earnings (TTM) | -$7.8M | ROE | −14.85% |
| Net Margin | −28.09% | ROIC | −27.24% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −14.86% |
| Market Cap | $48.4M | Trading Days | 2510 |
| 52W High | 5.92 |
| 52W Low | 2.66 |
| % Off High | −50.34% |
| YTD | −26.13% | 1Y | −44.74% |
| 3Y | 1.38% | 5Y | −19.51% |
| 10Y | −51.00% | Since incept. (ann.) | −6.65% |
US 92% · CN 7% · Other 0%
| Ann. Volatility (1Y) | 74.29% | Ann. Volatility (3Y) | 76.45% |
| Sharpe (1Y) | −0.42 | Sharpe (3Y) | 0.41 |
| Max Drawdown (1Y) | −51.88% | Max Drawdown (3Y) | −70.08% |
| Beta (3Y, vs SPY) | 1.58 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MDAI | Spectral AI, Inc. | $49.6M | — |
| LUNG | Pulmonx Corp | $52.8M | — |
| AURX | Nuo Therapeutics, Inc. | $43.6M | — |
| SNWV | SANUWAVE Health, Inc. | $54.7M | 4.6 |
| DRIO | DarioHealth Corp. | $54.8M | 0.7 |
| XTNT | Xtant Medical Holdings, Inc. | $59.7M | 14.2 |
| PAVM | PAVmed Inc. | $39.1M | — |
| MCAG | Mountain Crest Acquisition Corp. V | $38.1M | — |
| LNSR | LENSAR, Inc. | $64.8M | — |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $67.1M | — |
| NSPR | InspireMD, Inc. | $32.1M | — |
| TELA Bio, Inc. |
| $30.0M |
| — |
